Related Experiment Video
Updated: Oct 17, 2025
06:59
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
129
Mycotic Pulmonary Aneurysm Managed With Covered Stent
Camilo A Alquichire-Luna1, Diego F García-Bohórquez1, Juan C Hernández-Vargas1
1MEDITA Research Group, 28014Universidad Industrial de Santander, Bucaramanga, Colombia.
Vascular and Endovascular Surgery
|October 9, 2021
Summary
Mycotic aneurysms in the pulmonary artery are rare. A novel endovascular stent placement successfully treated a patient with acute myeloid leukemia, offering a new management option.
Area of Science:
- Cardiology
- Infectious Diseases
- Hematology
Background:
- Mycotic aneurysms, infections of blood vessels, rarely affect the pulmonary artery.
- Pulmonary artery involvement presents diagnostic challenges and carries a high mortality risk.
Observation:
- A young adult with acute myeloid leukemia undergoing chemotherapy developed febrile neutropenia and recurrent bacteremia.
- The patient presented with hemoptysis, indicative of a potential pulmonary vascular issue.
Findings:
- Infection with Pseudomonas Aeruginosa and Klebsiella Pneumonie was identified as the cause of bacteremia.
- A rare case of mycotic aneurysm in the pulmonary artery was diagnosed.
Implications:
- The study highlights the first successful use of a covered endovascular stent for pulmonary artery mycotic aneurysm.
- This case suggests a potentially life-saving, individualized treatment approach for this rare condition.
- Early diagnosis and tailored management are crucial for improving outcomes in patients with pulmonary artery mycotic aneurysms.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
45
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
45
01:26Aneurysm III: Interprofessional Care
54
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
54
01:22Aneurysm IV: Nursing Management
42
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
42
01:27Mitral Stenosis IV: Nursing Management
73
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
73
01:24Cystic Fibrosis: Management
253
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
253
01:18Endocarditis III: Medical Management
46
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
46